OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Communications is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020	368
Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020	339
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy	327
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021	299
LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer	257
Cancer burden of major cancers in China: A need for sustainable actions	250
A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysis	187
Ferroptosis in cancer and cancer immunotherapy	171
Emerging role of deep learning‐based artificial intelligence in tumor pathology	168
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance	148
Boron neutron capture therapy: Current status and future perspectives	128
Non‐small cell lung cancer in China	122
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma	121
CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target	111
The FTO/miR‐181b‐3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer	104
Single‐cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy	104
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review	102
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer	96
Advancing to the era of cancer immunotherapy	85
A global assessment of recent trends in gastrointestinal cancer and lifestyle‐associated risk factors	80
New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer	76
Tumor‐associated macrophages in liver cancer: From mechanisms to therapy	73
Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase	72
Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression	69
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine	67

Breast cancer: an up‐to‐date review and future perspectives	67
Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art	66
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma	65
Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma	61
The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential	58
New insights into molecules and pathways of cancer metabolism and therapeutic implications	55
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities	54
Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy	47
Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells	46
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy	46
Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China	43
N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA	42
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program	42
Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa‐miR‐6887‐3p	41
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives	41
Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges	40
Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma	40
The theory of tumor ecosystem	39
The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells	39
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy	38
Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study	38
S100A8 promotes epithelial‐mesenchymal transition and metastasis under TGF‐β/USF2 axis in colorectal cancer	37
Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine	36
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1	36
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer	32
Correlation between the genetic variants of base excision repair (BER) pathway genes and neuroblastoma susceptibility in eastern Chinese children	31
Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1‐mediated MAPK signaling	31
Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer	30
The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017	30
Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma	29
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates	29
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment	29
KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer	28
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors	28
Anti‐PD‐L1/TGF‐βR fusion protein (SHR‐1701) overcomes disrupted lymphocyte recovery‐induced resistance to PD‐1/PD‐L1 inhibitors in lung cancer	28
Atezolizumab plus bevacizumab versus sorafenib as first‐line treatment for unresectable hepatocellular carcinoma: a cost‐effectiveness analysis	27
Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma	27
The EGFR‐P38 MAPK axis up‐regulates PD‐L1 through miR‐675‐5p and down‐regulates HLA‐ABC via hexokinase‐2 in hepatocellular carcinoma cells	27
Elevated neutrophil extracellular traps by HBV‐mediated S100A9‐TLR4/RAGE‐ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma	27
Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors	27
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities	26
Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma	26
Application of erector spinae plane block guided by ultrasound for postoperative analgesia in breast cancer surgery: A randomized controlled trial	25
A newly discovered role of metabolic enzyme PCK1 as a protein kinase to promote cancer lipogenesis	25
Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T‐cell acute lymphoblastic leukemia	24
Analysis of the Global Burden of Disease study highlights the trends in death and disability‐adjusted life years of leukemia from 1990 to 2017	24
T‐cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications	24
Tumor microenvironment signaling and therapeutics in cancer progression	23
N⁶‐methyladenosine Steers RNA Metabolism and Regulation in Cancer	23
Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration?	23

Predictions of mortality related to four major cancers in China, 2020 to 2030	23
KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progression	22
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor	22
CRISPR/Cas9 screening identifies a kinetochore‐microtubule dependent mechanism for Aurora‐A inhibitor resistance in breast cancer	22
Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?	21
Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox	21
PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism	21
The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large‐scale cohort study in China	20
Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis	20
Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis	20
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, r	20
Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β₂‐AR/MACC1 axis	20
Lipid metabolism in pancreatic cancer: emerging roles and potential targets	20
Metabolic regulation in the immune response to cancer	19
Haploidentical‐ versus identical‐sibling transplant for high‐risk pediatric AML: A multi‐center study	19
Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib	19
Gene amplification‐driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A‐YTHDF2‐dependent in lung adenocarcinoma	19
The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation	18
RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment	18
Exhaled breath diagnostics of lung and gastric cancers in China using nanosensors	18
Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis	18
Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions	17
METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression	17
Emerging radiotherapy technologies and trends in nasopharyngeal cancer	17
Ki‐67 index, progesterone receptor expression, histologic grade and tumor size in predicting breast cancer recurrence risk: A consecutive cohort study	17
Expert opinions on immunotherapy for patients with colorectal cancer	17
Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients	17
YB1 regulates miR‐205/200b‐ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma	16
Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma	16
ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3	16
Harness the functions of gut microbiome in tumorigenesis for cancer treatment	16
LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex‐mediated changes in chromatin structure in lung adenocarcinoma	15
m⁶A‐mediated regulation of PBX1‐GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels	15
Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS)	15
Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide‐induced high tumor mutational burden	15
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients	15
Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis‐associated cancer	15
Ovarian cancer‐excreted exosomal miR‐199a‐5p suppresses tumor metastasis by targeting hypoxia‐inducible factor‐2α in hypoxia microenvironment	15
Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges	15
P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer	15
Crosstalk between IL‐15Rα⁺tumor‐associated macrophages and breast cancer cells reduces CD8⁺T cell recruitment	15
Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4	14
Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China	14
Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives	14
The role of myeloid‐derived suppressor cells in gastrointestinal cancer	13
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma	13
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A m	13
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study	13
Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials	13
Snail acetylation by autophagy‐derived acetyl‐coenzyme A promotes invasion and metastasis of KRAS‐LKB1 co‐mutated lung cancer cells	13
A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability	13
Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China	13
Macrophage inhibitory cytokine‐1 induced by a high‐fat diet promotes prostate cancer progression by stimulating tumor‐promoting cytokine production from tumor stromal cells	12
Abscopal effect of stereotactic radiotherapy combined with anti‐PD‐1/PD‐L1 immunotherapy: Mechanisms, clinical efficacy, and issues	12
Dicer‐independent snRNA/snoRNA‐derived nuclear RNA 3 regulates tumor‐associated macrophage function by epigenetically repressing inducible nitric oxide synthase transcription	12
A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy	12
Antibody variable region engineering for improving cancer immunotherapy	12
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation	12
Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)	12
CD70‐targeting CAR‐T cells have potential activity against CD19‐negative B‐cell Lymphoma	12
Pivotal roles of tumor‐draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy	12
PKCβII–ACSL4 pathway mediating ferroptosis execution and anti‐tumor immunity	11
Gene signatures associated with genomic aberrations predict prognosis in neuroblastoma	11
Germline polymorphisms of circadian genes and gastric cancer predisposition	11
XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)	11
miR‐495 and miR‐5688 are down‐regulated in non‐small cell lung cancer under hypoxia to maintain interleukin‐11 expression	11
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy	11
Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management	11
The establishment of polypeptide PSMA‐targeted chimeric antigen receptor‐engineered natural killer cells for castration‐resistant prostate cancer and the induction of ferroptosis‐related cell death	11
A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82	11
Association between glioblastoma cell‐derived vessels and poor prognosis of the patients	10
MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma	10
Machine learning models for outcome prediction of Chinese uveal melanoma patients: A 15‐year follow‐up study	10
RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells	10
Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer	10
Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer	10
Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome	10
Childhood overweight and risk of obesity‐related adult cancer in men	10
Involvement of long non‐coding RNAs in the progression of esophageal cancer	9
N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway	9

Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?	9
Circ_ASPH promotes cholangiocarcinoma growth and metastasis through the miR‐581/ATP‐binding cassette transporter G1 signaling pathway	9
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding‐dependent modality	9
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy	9
Impact of diabetes on promoting the growth of breast cancer	9
Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center	9
Phospholipase iPLA2β acts as a guardian against ferroptosis	9
PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c‐Myc‐mediated positive feedback loop	9
miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies	9
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope	8
Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives	8
Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study	8
Surgery as an alternative to radiotherapy in early‐stage nasopharyngeal carcinoma: innovation at the expense of uncertainty	8
PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression	8
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer	8
BAALC‐AS1/G3BP2/c‐Myc feedback loop promotes cell proliferation in esophageal squamous cell carcinoma	8
The ongoing trends of patient‐derived xenograft models in oncology	7
Improved esophageal squamous cell carcinoma screening effectiveness by risk‐stratified endoscopic screening: evidence from high‐risk areas in China	7
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer	7
Psychological and physiological impacts of a fast‐track diagnostic workup for men with suspected prostate cancer: Preliminary report from a randomized clinical trial	7
Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows	7
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract	7
Evaluation of renal cancer progression in a mouse model of heart failure	7
Long noncoding RNA PVT1 promotes tumor growth and predicts poor prognosis in patients with diffuse large B‐cell lymphoma	7
Roles and implications of mRNA N⁶‐methyladenosine in cancer	7
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD‐3 study	6
The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression	6
The prognostic significance of non‐sentinel lymph node metastasis in cutaneous and acral melanoma patients—A multicenter retrospective study	6
Co‐occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome	6
Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer	6
	6
Genetic alternations and immune characteristics in patients with small cell lung cancer	6
A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells	6
Structural and functional characterization of multiple myeloma associated cytoplasmic poly(A) polymerase FAM46C	6
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors	6
Germline mutational profile of Chinese patients under 70 years old with colorectal cancer	6
Association of chromosome 7 aneuploidy measured by fluorescence in situ hybridization assay with muscular invasion in bladder cancer	6
Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy	6
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases	6
DNA crosslinking and recombination‐activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia	6
Radioimmunotherapy‐induced intratumoral changes in cervical squamous cell carcinoma at single‐cell resolution	6
SDCBP‐AS1 destabilizes β‐catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis	6
Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low‐dose metformin	6
Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma	6
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target	6
Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates	6
Bone marrow metastasis from advanced gastric cancer complicated with disseminated intravascular coagulation: a highly aggressive but manageable disease subtype	5
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis	5
Lipid droplets: could they be involved in cancer growth and cancer–microenvironment communications?	5
Safety and efficacy of toripalimab in advanced gastric cancer: A new clinical trial bringing hope for immunotherapy in gastric cancer	5
Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi‐phased study of prostate cancer	5
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer	5
A safe and effective surgical navigation technique in laparoscopic radical gastrectomy: Indocyanine green‐mediated near‐infrared fluorescent imaging	5
Characterization of DNA damage response deficiency in pancreatic cancer patients from China	5
Aspirin‐based chemoprevention of colorectal cancer: The role for gut microbiota	5
The crosstalk between ferroptosis and anti‐tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy	5
Non‐recovery of renal function was correlated with increased mortality in the cancer cohort with septic shock	5
Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases	5
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study	5
JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps	5
Metabolon: a novel cellular structure that regulates specific metabolic pathways	4
CircBA1 derived from BCR‐ABL fusion gene inhibits cell proliferation in chronic myeloid leukemia	4
Transcriptional suppression of CD8⁺ T cell exhaustion for improving T cell immunotherapy	4
Licochalcone A suppresses Sp1 expression with potential anti‐myeloma activity	4
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis	4
Transcription factor TFE3 enhances cell cycle and cancer progression by binding to the hTERT promoter	4
Association of an anaplastic lymphoma kinase pathway signature with cell de‐differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer	4
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study	4
Colorectal cancer risk following appendectomy: a pooled analysis of three large prospective cohort studies	4
Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy	4
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas	4
μ‐opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial	4
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment	4
Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors	4
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study	4
Association between antipsychotic agents and risk of lung cancer: a nested case‐control study	4
Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending	4
Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations	4
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins	4
Role of eIF4E on epithelial‐mesenchymal transition, invasion, and chemoresistance of prostate cancer cells	4
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis	4
Proteomics identifies EGF‐like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor‐positive glioma	4
Long non‐coding RNA MILNR1 retards colorectal cancer growth by inhibiting c‐Myc	4
A novel histone deacetylase inhibitor exerts promising anti‐breast cancer activity via triggering AIFM1‐dependent programmed necrosis	4
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2	4
Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors	4
Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line	4
Pre‐transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors	4
Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers	4
Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis	4
Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2	4
	3
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy	3
	3
Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials	3